Oktay, Y;
Ulgen, E;
Can, O;
Akyerli, CB;
Yuksel, S;
Erdemgil, Y;
Durasi, IM;
... Ozduman, K; + view all
(2016)
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
Scientific Reports
, 6
, Article 27569. 10.1038/srep27569.
Text (Published article)
Oktay_IDH-mutant_glioma.pdf - Published Version Download (1MB) |
|
Preview |
Text (Supplementary information)
Oktay_IDH-mutant_glioma_S1.pdf Download (1MB) | Preview |
Spreadsheet (Supplementary table 1)
Oktay_IDH-mutant_glioma_Table1.xls Download (30kB) |
|
Spreadsheet (Supplementary table 2)
Oktay_IDH-mutant_glioma_Table2.xls Download (41kB) |
|
Spreadsheet (Supplementary table 3)
Oktay_IDH-mutant_glioma_Table3.xls Download (42kB) |
|
Spreadsheet (Supplementary table 4)
Oktay_IDH-mutant_glioma_Table4.xls Download (50kB) |
|
Spreadsheet (Supplementary table 5)
Oktay_IDH-mutant_glioma_Table5.xls Download (58kB) |
|
Spreadsheet (Supplementary table 6)
Oktay_IDH-mutant_glioma_Table6.xls Download (35kB) |
|
Spreadsheet (Supplementary table 7)
Oktay_IDH-mutant_glioma_Table7.xls Download (41kB) |
Abstract
The single nucleotide polymorphism rs55705857, located in a non-coding but evolutionarily conserved region at 8q24.21, is strongly associated with IDH-mutant glioma development and was suggested to be a causal variant. However, the molecular mechanism underlying this association has remained unknown. With a case control study in 285 gliomas, 316 healthy controls, 380 systemic cancers, 31 other CNS-tumors, and 120 IDH-mutant cartilaginous tumors, we identified that the association was specific to IDH-mutant gliomas. Odds-ratios were 9.25 (5.17–16.52; 95% CI) for IDH-mutated gliomas and 12.85 (5.94–27.83; 95% CI) for IDH-mutated, 1p/19q co-deleted gliomas. Decreasing strength with increasing anaplasia implied a modulatory effect. No somatic mutations were noted at this locus in 114 blood-tumor pairs, nor was there a copy number difference between risk-allele and only-ancestral allele carriers. CCDC26 RNA-expression was rare and not different between the two groups. There were only minor subtype-specific differences in common glioma driver genes. RNA sequencing and LC-MS/MS comparisons pointed to significantly altered MYC-signaling. Baseline enhancer activity of the conserved region specifically on the MYC promoter and its further positive modulation by the SNP risk-allele was shown in vitro. Our findings implicate MYC deregulation as the underlying cause of the observed association.
Type: | Article |
---|---|
Title: | IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/srep27569 |
Publisher version: | http://dx.doi.org/10.1038/srep27569 |
Language: | English |
Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology |
URI: | https://discovery.ucl.ac.uk/id/eprint/1509967 |
Archive Staff Only
View Item |